Certificate of Analysis (COA)
View the laboratory certificate for this product
[ View COA ]
Pure Semax 10mg research peptide vial
R 720.00
Pure Semax 10 mg Research Peptide is a research-grade synthetic peptide supplied for laboratory and scientific research applications. Semax is an ACTH-derived peptide analogue investigated in experimental neuroscience and neurobiology research.
Research involving Semax has examined cognitive processes, neuroprotective mechanisms, neurotrophic signalling and BDNF-related pathways, making it a subject of interest in peptide pharmacology and neurological research.
Pure Semax is supplied as a 10 mg research presentation with a 99% purity specification and third-party verification.
Key Research Areas
Cognitive and neurobiology research
Neuroprotective pathway research
Neurotrophic signalling
BDNF-related research
Peptide pharmacology
Cellular signalling
Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.
• Research-grade peptide compound
• Investigated in laboratory research involving neuropeptide signalling and neurological pathways
• Suitable for controlled biochemical and laboratory research applications
• 10mg research presentation
• Supplied for research purposes only
Semax is a synthetic peptide analogue derived from an ACTH-related sequence. Experimental research has investigated its effects on neuronal and neurotrophic signalling, including pathways associated with BDNF expression.
Research findings are largely dependent on experimental model, methodology and study conditions. The scientific literature should therefore be interpreted within the context of preclinical and laboratory research.
Research classification: Cognitive research / neurobiology / neurotrophic signalling / peptide pharmacology.
Research Reference
PURE Labs categorises Semax under Cognitive & Longevity Research and describes it as an ACTH analogue studied for cognitive function, BDNF levels and neuroprotection.
Scientific literature on Semax includes experimental investigation of neuroprotective and neurotrophic mechanisms, including BDNF-related pathways.
Semax is a synthetic heptapeptide related to the ACTH(4–10) fragment and has been investigated in neurobiology research. Experimental studies have reported interactions associated with neurotrophic signalling, including increased brain-derived neurotrophic factor (BDNF) in animal models. Research findings should be interpreted as preclinical or investigational evidence rather than a general clinical claim. For laboratory research use only.
